Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCCAP.L Regulatory News (CCAP)

  • There is currently no data for CCAP

Q3 2013 AUM Update

11 Oct 2013 15:28

RNS Number : 3509Q
Charlemagne Capital Limited
11 October 2013
 



Charlemagne Capital Limited

 

11 October 2013

 

Charlemagne Capital Announces Unaudited Assets under Management as at 30 September 2013

 

Charlemagne Capital Limited ("Charlemagne" or the "Group") sets out below the Assets under Management ("AuM") as at 30 September 2013 and the movements for the third quarter of its current financial year.

 

Group AuM

 

Group AuM total up 5.4% in the quarter to US$2.55 billion as at 30 September 2013 reflecting the improved market conditions during the most recent quarter.

 

The table below sets out the Group's AuM as at 30 September 2013 and the movements experienced in each product range in the period since 1 July 2013.

 

01-Jul-13

Net Subscriptions

Net Performance

30-Sep-13

Movement In

AuM (US$m)

(US$m)

(%)

(US$m)

(%)

AuM (US$m)

Period (%)

Magna

420

1

0.2

24

5.7

445

6.0

OCCO

586

9

1.5

23

3.9

618

5.5

Institutional

1,288

(18)

(1.4)

92

7.2

1,362

5.7

Specialist

124

2

1.6

(2)

(1.6)

124

0.0

Total

2,418

(6)

(0.2)

137

5.7

2,549

5.4

 

Notes:

(1) Closing AuM is stated as including all subscription and redemption orders received for the relevant funds as at the close of the period but not processed until the first relevant dealing date of the following period.

(2) Net performance includes foreign currency effects for those assets not denominated in US dollars.

 

 

Enquiries:

 

Charlemagne Capital

Jayne Sutcliffe, Chief Executive Tel. 020 7518 2100

Lloyd Jones, Chief Financial Officer Tel. 01624 640200

 

Smithfield Consultants Tel. 020 7360 4900

John Kiely

Ged Brumby

 

N+1 Singer (Nominated Adviser) Tel. 020 7496 3000

Jonny Franklin-Adams

Nick Donovan

 

This announcement is not for release, publication or distribution, in whole or in part, directly or indirectly, in or into the United States of America, Australia, Canada, Japan or South Africa or any other jurisdiction into which the release, publication or distribution would be unlawful. Any failure to comply with this restriction may constitute a violation of United States, Australian, Canadian, Japanese, South African or other securities law. The distribution of this announcement in jurisdictions other than the United Kingdom may be restricted by law and persons into whose possession this announcement comes should inform themselves about and observe any such restrictions.

 

This announcement contains (or may contain) certain forward-looking statements with respect to the financial condition, results of operations and businesses of the Group. These statements and forecasts are based on Charlemagne's beliefs, assumptions and expectations of the Group's future performance. These beliefs, assumptions and expectations can change as a result of many possible events or factors, not all of which are known to Charlemagne at the date of this announcement or are within its control, that could cause actual results or developments to differ materially from those expressed or implied by these forward-looking statements. Data or statements contained in this announcement regarding past trends or activities should not be taken as a representation that such trends or activities will continue in the future. Nothing in this announcement should be construed as a profit forecast or to imply that the earnings of the Company for the current or future financial years will necessarily match or exceed the historical or published earnings of the Group.

 

This announcement is for information purposes only and shall not constitute an offer to buy, sell, issue or subscribe for, or the solicitation of an offer to buy, sell, issue, or subscribe for, any securities in Charlemagne or any other entity. This announcement is aimed at providing information regarding the Assets under Management on which revenue is derived by Charlemagne. The unaudited data contained in this announcement are currently provisional and all such data are subject to change without notice and, except as required by applicable law, neither Charlemagne nor Singer Capital Markets assumes any responsibility or obligation to update publicly or review any of the data or statements contained herein.

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCZMMMGDMKGFZM
Date   Source Headline
20th Jan 20219:05 amRNSSecond Price Monitoring Extn
20th Jan 20219:00 amRNSPrice Monitoring Extension
18th Jan 202110:00 amRNSIssue of Equity and Total Voting Rights
12th Jan 20218:22 amRNSTR-1: Notification of major holdings
11th Jan 20214:35 pmRNSPrice Monitoring Extension
11th Jan 202111:31 amRNSIssue of Equity and Total Voting Rights
11th Jan 20219:00 amRNSTR-1: Notification of major holdings
11th Jan 20217:00 amRNSTR-1: Notification of major holdings
7th Jan 20219:05 amRNSSecond Price Monitoring Extn
7th Jan 20219:00 amRNSPrice Monitoring Extension
6th Jan 20215:32 pmRNSTR-1: Notification of major holdings
2nd Dec 20202:06 pmRNSSecond Price Monitoring Extn
2nd Dec 20202:00 pmRNSPrice Monitoring Extension
20th Nov 20209:05 amRNSSecond Price Monitoring Extn
20th Nov 20209:00 amRNSPrice Monitoring Extension
18th Nov 20207:00 amRNSTR-1: Notification of major holdings
19th Oct 20202:41 pmRNSWarrant Update
7th Oct 20202:05 pmRNSSecond Price Monitoring Extn
7th Oct 20202:00 pmRNSPrice Monitoring Extension
6th Oct 20203:08 pmRNSNew Website
14th Dec 20164:01 pmRNSScheme Effective
13th Dec 20164:15 pmRNSCourt Sanction of Scheme
13th Dec 20167:30 amRNSSuspension - Charlemagne Capital Limited
12th Dec 20168:05 amRNSDocument re: Charlemagne Capital
12th Dec 20168:01 amRNSSuspension of Dealings and Transfers
9th Dec 201610:55 amRNSDocument re: Charlemagne Capital
8th Dec 20161:22 pmRNSConfirmation of Regulatory Clearance
8th Dec 201611:36 amRNSDocument re: Charlemagne Capital
7th Dec 20164:25 pmRNSDocument re: Charlemagne Capital
7th Dec 20164:21 pmRNSDocument re: Charlemagne Capital
2nd Dec 20165:19 pmRNSResults of the Court Meeting
10th Nov 20167:00 amRNSScheme Circular
14th Oct 20163:05 pmRNSDocument re: Charlemagne Capital
12th Oct 20167:00 amRNSQ3 2016 AUM Update
3rd Oct 20163:30 pmRNSTR-1: Notification of Major Interest in Shares
30th Sep 20163:01 pmRNSOPD - Charlemagne Capital - Replacement
30th Sep 20162:50 pmRNSDoc re. Charlemagne Capital
30th Sep 20167:00 amRNSForm 8 (OPD) Charlemagne Capital plc
30th Sep 20167:00 amRNSRecommended Cash Offer for Charlemagne
30th Sep 20167:00 amRNSHalf Yearly Report
19th Sep 201611:01 amRNSTR-1: Notification of Major Interest in Shares
14th Jul 20167:00 amRNSTrading Statement
27th Jun 20164:40 pmRNSSecond Price Monitoring Extn
27th Jun 20164:35 pmRNSPrice Monitoring Extension
17th Jun 20161:56 pmRNSResult of AGM
20th May 20164:38 pmRNSAnnual Report and Notice of AGM
28th Apr 20161:22 pmRNSTR-1: Notification of Major Interest in Shares
15th Apr 201610:08 amRNSTR-1: Notification of Major Interest in Shares
11th Apr 20167:00 amRNSQ1 2016 AUM Update
24th Mar 20169:16 amRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.